$30+ Bn Pharmaceutical Manufacturing Equipment Market Analysis by Equipment Type, End Product, Technology - Global Forecast to 2032
Dublin, May 07, 2026 (GLOBE NEWSWIRE) -- The "Pharmaceutical Manufacturing Equipment Market by Equipment Type, End Product, Technology - Global Forecast to 2032" has been added to ResearchAndMarkets.com's offering.
The global pharmaceutical manufacturing equipment market size is projected to grow from USD 21.24 billion in 2026 to USD 30.39 billion by 2032, achieving a CAGR of 6.2% during the forecast period.
This growth is driven by the increasing demand for efficient and compliant drug production systems, expanded production capacities, and rigorous regulations driving modernization across pharmaceutical production lines. The burgeoning demand for generic drugs and biologics supports scalable manufacturing solutions, with a focus on high-quality, validated equipment. Investment in pharmaceutical infrastructure continues to gain momentum, supporting the adoption of advanced manufacturing equipment globally.
Key industry players include GEA Group Aktiengesellschaft (Germany), IMA Industria Macchine Automatiche S.p.A (Italy), Syntegon Technology GmbH (Germany), ACG (India), Thermo Fisher Scientific Inc (US), among others.
Packaging Machines Segment Growth
The packaging machines segment is expected to record the highest CAGR by 2032. The focus on pharmaceutical packaging safety and compliance propels growth, with companies emphasizing product protection and shelf life extension. Strict regulations fuel investment in sophisticated packaging systems, while the production rise in tablets, capsules, and injectables increases packaging demand. The shift towards automation and serialization technologies for traceability and anti-counterfeiting needs accelerates the demand for advanced packaging machinery across the industry.
Dominance of Liquid Segment
The liquid segment is anticipated to dominate the pharmaceutical manufacturing equipment market due to increased demand for injectables and biologic drugs. The production of vaccines and oral liquid medicines drives further growth. Chronic disease prevalence demands higher sterile formulation outputs, while immunization program expansions bolster demand regionally. Investments in advanced filling and sealing systems, alongside growth in contract manufacturing, support substantial infrastructure expansion in liquid formulary production.
China's Leading Market Position
China commanded the largest share of the Asia Pacific pharmaceutical manufacturing equipment market as of 2025, attributed to its vast production capacity. The country remains a leader in active pharmaceutical ingredient (API) and generic drug manufacturing, underpinned by advanced automated production lines across diverse facilities. Growing investments in biologics and vaccines necessitate enhanced manufacturing equipment. Contract manufacturing growth and facility modernization to meet international standards further stimulate demand, positioning China as a dominant market player.
Key Attributes:
Key Topics Covered:
Market Dynamics
Drivers
Challenges
Case Studies
Opportunities
Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/24cfxm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment